StockTipsArenaBeta

Caplin Point Laboratories Share price target & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹2,249.1+27.50 (+1.24%)

Only one active 1–3 month target

The short-term call is BUY

₹3,30046.7% above today's price

Caplin Point Laboratories has one active 1–3 month share price target: ₹3,300 from Shrikant Chouhan, Kotak Securities (24 Sept 2026). One target is a single view, not a consensus.

1
1 BUY · 0 SELL, all horizons
1
with an active 1–3M target
53%
9 of 17 closed calls hit
18
all horizons, open and closed
Watch CAPLIPOINT for new buy/sell callsGet alertsSee 44 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

All tips (18)

BUYTarget₹2,320
ISbyICICI SecuritiesTarget hit
1 Year* · 15 May 2026 · entry ₹1,998.8 · via Institutional / Brokerage Researchexit ₹2,320
BUYTarget₹2,155
ISbyICICI SecuritiesTarget hit
1 Year* · 6 Feb 2026 · entry ₹1,825.7 · via Institutional / Brokerage Researchexit ₹2,155
BUYTarget₹2,295
ISbyICICI SecuritiesTarget hit
1 Year* · 10 Nov 2025 · entry ₹1,943.2 · via Institutional / Brokerage Researchexit ₹2,295
BUYTarget₹2,400
ISbyICICI SecuritiesTarget hit
1 Year* · 11 Nov 2024 · entry ₹2,012.2 · via Institutional / Brokerage Researchexit ₹2,400
BUYTarget₹1,980
ISbyICICI SecuritiesTarget hit
1 Year* · 8 Aug 2024 · entry ₹1,481.7 · via Institutional / Brokerage Researchexit ₹1,980
BUYTarget₹1,535
ISbyICICI SecuritiesTarget hit
1 Year* · 19 Mar 2024 · entry ₹1,276.05 · via Institutional / Brokerage Researchexit ₹1,535
BUYTarget₹3,850
SJbySachin Janardan Sarvade, IDBI Capital Markets and SecuritiesStop-loss hit
1 Year* · 25 Sept 2026 · entry ₹2,890 · via NDTV Profit (Live)exit ₹2,379
BUYTarget₹3,500
KSbyKunal SaraogiStop-loss hit
1 Year* · 11 Sept 2026 · entry ₹2,733.7 · via Zee Business (Live)exit ₹2,700
BUYTarget₹3,300
SCbyShrikant Chouhan, Kotak Securities+46.7% to target
1–3 Months · 2 mo left · 24 Sept 2026 · entry ₹2,974.4 · via NDTV ProfitP&L -24.4%
BUYTarget₹3,290
MIbyMarketSmith IndiaStop-loss hit
1–3 Months · 25 Sept 2026 · entry ₹2,859.5 · via LiveMint Buy-or-Sell (topic)exit ₹2,690
BUYTarget₹2,800
RJbyRuchit Jain, Motilal OswalTarget hit
1–2 Weeks* · 2 Sept 2026 · entry ₹2,710 · via NDTV Profit (Live)exit ₹2,800
BUYTarget₹2,850
RPbyRajesh Palviya, Axis SecuritiesTarget hit
1–2 Weeks* · 2 Sept 2026 · entry ₹2,710 · via ET Now (Live)exit ₹2,850
BUYTarget₹2,670
RVbyRachna VaidyaTarget hit
1–2 Weeks* · 30 Jun 2026 · entry ₹2,633 · via CNBC Awaaz.exit ₹2,670
BUYTarget₹3,100
AKbyAshish Kyal, Waves Strategy AdvisorsStop-loss hit
1–2 Weeks* · 24 Sept 2026 · entry ₹2,861.6 · via ET Now (Live)exit ₹2,756
BUYTarget₹3,300
ASbyAmit Shreeram GoelStop-loss hit
1–2 Weeks* · 24 Sept 2026 · entry ₹2,963.1 · via NDTV Profit (Live)exit ₹2,800
BUYTarget₹2,600
AJbyAnsh Jogendra BhilwarStop-loss hit
Intraday* · 28 Aug 2026 · entry ₹2,553.3 · via Zee Business Stocksexit ₹2,524
BUYTarget₹3,000
KSbyKunal SaraogiExpired
Intraday* · 24 Sept 2026 · entry ₹2,938.9 · via Zee Business (Live)exit ₹2,882.1
BUYTarget₹2,770
SBbySumeet Bagadia, Choice BrokingExpired
Intraday · 18 Sept 2026 · entry ₹2,704 · via Zee Business (Live)exit ₹2,748.6

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks